JP Morgan Chase
EDVA

JP Morgan Chase’s Endovia Health Sciences, Inc. EDVA Stock Holding History

JP Morgan Chase’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$4 – 7569
2025
Q1 		$4 Hold
1
– – ﹤0.01% 7237
2024
Q4 		$20 Hold
1
– – ﹤0.01% 7270
2024
Q3 		$30 Hold
1
– – ﹤0.01% 7203
2024
Q2 		$23 Hold
1
– – ﹤0.01% 7156
2024
Q1 		$41 Buy
+1
New +$80 ﹤0.01% 7074
2023
Q4 		– Hold
0
– – – 7239
2023
Q3 		– Hold
0
– – – 7158

Other funds holding EDVA

CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

JP Morgan Chase's EDVA Position: Q2 2025 in Review

JP Morgan Chase sold out of Endovia Health Sciences, Inc. (EDVA) in Q2 2025, closing a stake of 1 share — an estimated $4 sold.

JP Morgan Chase first reported a position in EDVA in Q1 2024 and held it in 5 quarters. The position peaked at $41 in Q1 2024. 12 funds tracked by Wall St. Rank hold EDVA as of Q2 2025.

  • JP Morgan Chase reported no remaining Endovia Health Sciences, Inc. position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 1 Endovia Health Sciences, Inc. share in Q2 2025, an estimated $4.
  • JP Morgan Chase first reported a position in Endovia Health Sciences, Inc. in Q1 2024 and held it in 5 quarters.
  • JP Morgan Chase's Endovia Health Sciences, Inc. position peaked at $41 in Q1 2024.
  • 12 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.